CAJ | 학술논문

目的：探讨头痛宁胶囊治疗伴卒中相关危险因素的头痛的疗效。方法选取60例伴卒中相关危险因素的头痛患者，分为治疗组和对照组各30例，治疗组给予常规治疗及头痛宁胶囊，对照组只给予常规治疗。结果治疗4周后，治疗组的头痛缓解率为93％，对照组的头痛缓解率为63％，两组患者在头痛的发作频率、持续时间及疼痛程度方面比较差异均有统计学意义（P＜0．05）。结论加用头痛宁胶囊对伴卒中相关危险因素的头痛患者疗效更佳。
목적：탐토두통저효낭치료반졸중상관위험인소적두통적료효。방법선취60례반졸중상관위험인소적두통환자，분위치료조화대조조각30례，치료조급여상규치료급두통저효낭，대조조지급여상규치료。결과치료4주후，치료조적두통완해솔위93％，대조조적두통완해솔위63％，량조환자재두통적발작빈솔、지속시간급동통정도방면비교차이균유통계학의의（P＜0．05）。결론가용두통저효낭대반졸중상관위험인소적두통환자료효경가。
Objective To investigate the effect of Toutongning capsule for treatment of headache with stroke-associated risk fac-tors .Methods 60 cases of headache patients with stroke-associated risk factors were selected and divided into the treatment group and the control group ,30 cases in each group .The treatment group were given conventional therapy plus Toutongning capsule while the control group were given conventional therapy only .Results After 4 weeks ,the remission rate of treatment group was 93% and that of the control group was 63% .The attack frequency ,duration and degree between the two groups showed statistically signifi-cant difference(P<0 .05) .Conclusion Additional Toutongning capsule has a better effect for treatment of headache with stroke-as-sociated risk factors.